A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis. Khalid U, Simovic M, Hammann LA, Iskar M, et al. Int J Cancer 2022;151:590-606.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khalid U, Simovic M, Hammann LA, Iskar M, et al. A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis. Int J Cancer 2022;151:590-606.
PMID: 35411591